Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02188173 · ClinicalTrials.gov registry record
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 200
- Enrollment target
NCT02188173 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 200 participants.
The verdict
NCT02188173 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).
Interventions
- DRUG dexamethasone 700 ㎍ intravitreal implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02188173
The ClinicalTrials.gov registry entry for NCT02188173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dexamethasone 700 ㎍ intravitreal implant is the first listed.
NCT02188173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02188173 about?
NCT02188173 is a clinical study titled "An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)". This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).
What is the current status of trial NCT02188173?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2014-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02188173?
The interventions under investigation include: dexamethasone 700 ㎍ intravitreal implant (DRUG).
Who is sponsoring clinical trial NCT02188173?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.